3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
7
Phase 1
5
Phase 2
4
Phase NA
2
Phase 4
2
Phase 2/3
1
Status
Terminated
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
20
Polycystic Ovary Syndrome
6
Infertility
4
Neoplasm Metastasis
2
Leiomyoma
2
is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
1
Patient Acceptance of Health Care
1
Ovarian Cysts
1
Myofibroma
1
Locally Advanced Breast Cancer
1
Infertility, Female
1
Carcinoma, Ductal
1
Breast Neoplasm Malignant Female
1
Breast Carcinoma In Situ
1
Anovulation
1
Abortion, Spontaneous
1
Interventions
Zoledronic Acid
5
Bevacizumab
3
exemestane
2
Therapeutics
2
Standard of Care
2
Pamidronate
2
Oxaliplatin
2
Misoprostol
2
Magnetic Resonance Spectroscopy
2
Letrozole
2
Ibandronic Acid
2
Fulvestrant
2
Fluorouracil
2
Cetuximab
2
Capecitabine
2
vandetanib
1
palbociclib
1
liposomal doxorubicin
1
huaier
1
eribulin
1
enzalutamide
1
darolutamide
1
cabozantinib
1
aldesleukin
1
abemaciclib
1
Vindesine
1
Trastuzumab
1
Sugars
1
Stents
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Neoplasm Metastasis
×
Letrozole
×
Clear all
NCT03220178
2022-01-06
PRECYCLE
Palleos Healthcare GmbH
Phase 4
Terminated
532 enrolled
NCT00171847
2010-03-31
eLEcTRA
Novartis
Phase 4
Terminated
93 enrolled